المؤلفون: Paola Nasta, Giampiero Carosi, Massimo Puoti, Gabriella Verucchi, Ivana Maida, E. Angeli, Emanuele Pontali, Claudio Iannacone, Anna Maria Cattelan, Mariarosaria Giralda, Antonietta Caputo

المساهمون: Nasta, P, Maida, I, Cattelan, Am, Pontali, E, Angeli, E, Giralda, M, Verucchi, G, Caputo, A, Iannacone, C, Puoti, M, Carosi, G.

المصدر: Journal of Women's Health. 24:159-164

مصطلحات موضوعية: Adult, Male, Oncology, Aging, medicine.medical_specialty, Time Factors, Treatment outcome, HIV Infections, Hepacivirus, Interferon alpha-2, Logistic regression, Antiviral Agents, Polyethylene Glycols, Therapy naive, Virological response, chemistry.chemical_compound, Pegylated interferon, Internal medicine, Ribavirin, medicine, Humans, HIV Infections -- Drug Therapy Hepatitis C -- Drug Therapy Comorbidity Age Factors Blood Glucose -- Metabolism Viral Load Interferons -- Therapeutic Use Ribavirin -- Therapeutic Use Treatment Outcomes, Coinfection, business.industry, Interferon-alpha, virus diseases, General Medicine, Hepatitis C, Chronic, Middle Aged, Viral Load, Response to treatment, Recombinant Proteins, Glucose, Logistic Models, Treatment Outcome, Italy, chemistry, Immunology, HIV-1, RNA, Viral, Drug Therapy, Combination, Female, business, Viral load, medicine.drug

وصف الملف: STAMPA

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69df9bb4bed710a3b0f765ec7fdb7325
https://doi.org/10.1089/jwh.2014.4796

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Frank Jühling, Yujin Hoshida, Atsushi Ono, Thomas F. Baumert

المساهمون: Institut de Recherche sur les Maladies Virales et Hépatiques (IVH), Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM), L'Institut hospitalo-universitaire de Strasbourg (IHU Strasbourg), Institut National de Recherche en Informatique et en Automatique (Inria)-l'Institut de Recherche contre les Cancers de l'Appareil Digestif (IRCAD)-Les Hôpitaux Universitaires de Strasbourg (HUS)-La Fédération des Crédits Mutuels Centre Est (FCMCE)-L'Association pour la Recherche contre le Cancer (ARC)-La société Karl STORZ, Nouvel Hôpital Civil de Strasbourg, Icahn School of Medicine at Mount Sinai [New York] (MSSM), Hiroshima University, univOAK, Archive ouverte

المصدر: BMC Medicine
BMC Medicine, BioMed Central, 2017, 15 (1), ⟨10.1186/s12916-017-0815-7⟩
BMC Medicine, 2017, 15 (1), ⟨10.1186/s12916-017-0815-7⟩

مصطلحات موضوعية: 0301 basic medicine, Liver Cirrhosis, Hepatocellular carcinoma, Aucun, Hepacivirus, medicine.disease_cause, Direct-acting antivirals, Local/drug therapy/virology, Hepacivirus/physiology, 0302 clinical medicine, Interferon, Liver Cirrhosis/drug therapy/pathology/virology, Genotype, Sustained virologic response, Medicine(all), [SDV.MHEP] Life Sciences [q-bio]/Human health and pathology, Interferons/therapeutic use, Hepatitis C virus, Incidence (epidemiology), Liver Neoplasms, General Medicine, Hepatitis C, 3. Good health, Antiviral Agents/*therapeutic use, 030211 gastroenterology & hepatology, medicine.drug, Carcinoma, Hepatocellular, Liver Neoplasms/*drug therapy/epidemiology/*virology, Sciences du Vivant [q-bio]/Médecine humaine et pathologie, Hepatitis C/*complications/*drug therapy, Antiviral Agents, 03 medical and health sciences, Diabetes mellitus, medicine, Carcinoma, Humans, Hepatocellular/*drug therapy/*virology, business.industry, medicine.disease, Neoplasm Recurrence, 030104 developmental biology, Immunology, Minireview, Interferons, Neoplasm Recurrence, Local, business, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a92f14a1255d75d491b41a7c7c744b1
http://europepmc.org/articles/PMC5348895

المؤلفون: Melissa Shaughnessy, Jean-Pierre Bronowicki, Wayne Ghesquiere, Janice Wahl, Edward Gane, William Sievert, Laura Lester, Dominique Guyader, Martin Lagging, Eric Lawitz, Reem Ghalib, Luis A. Balart, Brian L. Pearlman, Laurent Alric, Michael N. Robertson, Peggy Hwang, Eliav Barr, Barbara Haber, Frank J. Dutko, Fredrik Sund, Edward Tam, Anita Y. M. Howe

المساهمون: University of Texas Health Science Center at San Antonio [San Antonio], Auckland City Hospital, Emory University School of Medicine, Emory University [Atlanta, GA], Lair Centre (Liver Health Centre), Foie, métabolismes et cancer, Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), Pharmacochimie et Biologie pour le Développement (PHARMA-DEV), Institut de Recherche pour le Développement (IRD)-Institut de Chimie de Toulouse (ICT-FR 2599), Institut National Polytechnique (Toulouse) (Toulouse INP), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Institut de Chimie du CNRS (INC)-Institut National Polytechnique (Toulouse) (Toulouse INP), Université Fédérale Toulouse Midi-Pyrénées-Institut de Chimie du CNRS (INC), Service d'Hépato-gastro-entérologie [CHRU Nancy], Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Nutrition-Génétique et Exposition aux Risques Environnementaux (NGERE), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), University of California, School of Public Health and Preventive Medicine [Monash University-Melbourne], Monash University [Melbourne], University of Texas at Arlington [Arlington], Tulane University, Uppsala University, Department of Infectious Diseases, University of Gothenburg (GU), Whitehouse Station, Merck & Co, Inc., University of Texas Health Science Center at San Antonio [San Antonio, Tx, USA], Université de Rennes (UR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), Institut de Recherche pour le Développement (IRD)-Institut de Chimie de Toulouse (ICT), Institut de Recherche pour le Développement (IRD)-Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université de Toulouse (UT)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS)-Institut National Polytechnique (Toulouse) (Toulouse INP), Université de Toulouse (UT)-Institut de Recherche pour le Développement (IRD)-Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT), University of California (UC)

المصدر: Lancet
Lancet, Elsevier, 2015, 385 (9973), pp.1075-86. ⟨10.1016/S0140-6736(14)61795-5⟩
The Lancet
The Lancet, 2015, 385 (9973), pp.1075-86. ⟨10.1016/S0140-6736(14)61795-5⟩

مصطلحات موضوعية: Liver Cirrhosis, Cyclopropanes, Male, [SDV]Life Sciences [q-bio], Hepacivirus, Gastroenterology, RNA Viral / blood, Polyethylene Glycols, chemistry.chemical_compound, 0302 clinical medicine, Pegylated interferon, 030212 general & internal medicine, Treatment Failure, Aged, 80 and over, Sulfonamides, Imidazoles, virus diseases, General Medicine, Hepatitis C, Middle Aged, Viral Load, 3. Good health, Liver Cirrhosis / etiology, Treatment Outcome, Grazoprevir, Cohort, RNA, Viral, Imidazoles / administration & dosage, Drug Therapy, Combination, 030211 gastroenterology & hepatology, Female, Hepacivirus / genetics, medicine.drug, Adult, medicine.medical_specialty, Elbasvir, Adolescent, Polyethylene Glycols / therapeutic use, Hepatitis C Chronic / drug therapy, Antiviral Agents, Drug Administration Schedule, 03 medical and health sciences, Young Adult, Drug Therapy Combination, Hepatitis C Chronic / complications, Quinoxalines, Internal medicine, Ribavirin, Quinoxalines / administration & dosage, medicine, Ribavirin / administration & dosage, Elbasvir, Grazoprevir, Humans, Benzofurans, Aged, business.industry, Hepatitis C, Chronic, Antiviral Agents / administration & dosage, medicine.disease, Amides, digestive system diseases, Surgery, Regimen, chemistry, Aged 80 and over, Interferons / therapeutic use, Benzofurans / administration & dosage, Interferons, Carbamates, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5499808d4b935bfcfa2818d08f9e2caa
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01142117

المؤلفون: Baur, Katharina, Mertens, Joachim C, Schmitt, Johannes, Iwata, Rika, Stieger, Bruno, Frei, Pascal, Seifert, Burkhardt, Bischoff Ferrari, Heike A, von Eckardstein, Arnold, Müllhaupt, Beat, Geier, Andreas, Negro, Francesco, Rubbia-Brandt, Laura

المصدر: Antiviral therapy
Antiviral Therapy, Vol. 17, No 3 (2012) pp. 541-7

مصطلحات موضوعية: Male, Hepacivirus, ddc:616.07, Calcitriol receptor, Polyethylene Glycols, Cohort Studies, chemistry.chemical_compound, Liver disease, 0302 clinical medicine, Pegylated interferon, Interferon, Medicine, Pharmacology (medical), Vitamin D, Antiviral Agents/therapeutic use, Interferons/therapeutic use, Hepatitis C, Chronic/drug therapy/genetics/virology, Hepatitis C, Middle Aged, 3. Good health, Infectious Diseases, Treatment Outcome, Vitamin D/blood, 030220 oncology & carcinogenesis, 030211 gastroenterology & hepatology, Drug Therapy, Combination, Female, medicine.drug, Adult, Genotype, Haplotypes/genetics, Ribavirin/therapeutic use, Polyethylene Glycols/therapeutic use, Antiviral Agents, Receptors, Calcitriol/genetics, vitamin D deficiency, 03 medical and health sciences, Ribavirin, Vitamin D and neurology, Humans, Aged, Pharmacology, Polymorphism, Genetic, business.industry, Hepatitis C, Chronic, medicine.disease, Hepacivirus/drug effects/genetics, chemistry, Haplotypes, Immunology, Receptors, Calcitriol, Interferons, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7dd8133265bfef26cb0fc89e531d57e9
https://pubmed.ncbi.nlm.nih.gov/22300961

المؤلفون: Laura Rubbia Brandt, James G. Kench, Jason M. Hui, Francesco Negro, Hossein Poustchi, Jacob George, Ian Homer Y. Cua

المصدر: Journal of Hepatology, Vol. 48, No 1 (2008) pp. 28-34

مصطلحات موضوعية: Blood Glucose, Liver Cirrhosis, Male, Hepacivirus, medicine.medical_treatment, ddc:616.07, medicine.disease_cause, Gastroenterology, Body Mass Index, chemistry.chemical_compound, Liver Function Tests, Insulin, Treatment Failure, Antiviral Agents/therapeutic use, Interferons/therapeutic use, biology, Hepatitis C, Middle Aged, Treatment Outcome, Liver, Female, Liver/pathology, Viral load, Hepatitis C, Chronic/pathology/physiopathology/therapy, Adult, medicine.medical_specialty, Genotype, Hepatitis C virus, Ribavirin/therapeutic use, Hepacivirus/genetics, Liver Cirrhosis/pathology, Antiviral Agents, Insulin resistance, Internal medicine, Ribavirin, medicine, Humans, ddc:610, Obesity, Aged, Hepatology, Blood Glucose/metabolism, business.industry, Hepatitis C, Chronic, biology.organism_classification, medicine.disease, Logistic Models, chemistry, Immunology, Interferons, Steatosis, Obesity/complications, Insulin Resistance, business, Insulin/blood, Insulin Resistance/physiology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aed7bafe05367e91cc42190494f5b2bf
https://pubmed.ncbi.nlm.nih.gov/17977612